share_log

4: Statement of changes in beneficial ownership of securities-Director McMullen Michael R.

SEC ·  Jul 3 05:37
Summary by Futu AI
Michael R. McMullen, associated with Bristol-Myers Squibb Co. [BMY], was involved in a transaction on 07/01/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. As such, the impact of this event on McMullen's holdings and the overall market position of Bristol-Myers Squibb remains unclear.
Michael R. McMullen, associated with Bristol-Myers Squibb Co. [BMY], was involved in a transaction on 07/01/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. As such, the impact of this event on McMullen's holdings and the overall market position of Bristol-Myers Squibb remains unclear.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.